Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04119024 |
|---|---|
| Brief Title: | Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma |
| First Submitted : | September 25, 2019 |
| First Submitted that Met QC Criteria : | October 4, 2019 |
| First Posted : | October 8, 2019 |
| Last Update Submitted that Met QC Criteria : | January 5, 2023 |
| Last Update Posted : | January 6, 2023 |